B. Thier

Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy.

D. Schadendorf, J. Becker, S. Ugurel, 2020, The Journal of clinical investigation.

Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity

D. Schadendorf, C. Coch, G. Hartmann, 2022, Journal for ImmunoTherapy of Cancer.

Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression

D. Schadendorf, A. Pandyra, D. Häussinger, 2020, Frontiers in Immunology.

Melanoma differentiation trajectories determine sensitivity towards pre-existing CD8+ tumor-infiltrating lymphocytes.

D. Schadendorf, A. Roesch, A. Sucker, 2021, The Journal of investigative dermatology.

HLA class II loss and JAK1/2 deficiency coevolve in melanoma leading to CD4 T cell and IFNγ cross-resistance.

D. Schadendorf, S. Ferrone, A. Roesch, 2023, Clinical cancer research : an official journal of the American Association for Cancer Research.